Post by peryannie4 on Aug 3, 2021 7:27:40 GMT -5
Gefitinib is sold under the trade name Iressa. It is used to treat lung cancer. It is an enzyme called tyrosine kinase. The Food and Drug Administration announced the approval in the month of May 2003 for the treatment of NSCLC, with minimal reported gefitinib side effects. The age bar was 59 years old and 41% of them were male. The effect of apatinib gefitinib combination has progression-free survival having a median of 13.7 months with gefitinib 250 mg tablet. The Gefitinib price is around INR 11226 for 30 tablets (250 mg) supply.